未登录

D

Daniel A. Mitchell

Cedars Sinai Medical Center

H指数:45

被引数:9,404

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comprehensive Unified Regimen for Eliminating Undiagnosed/Untreated Aortic Valve Stenosis: Algorithm Validation for Identifying Aortic Stenosis and Treatment Disparities

综合统一方案以消除未诊断/未治疗的主动脉瓣狭窄：识别主动脉狭窄和治疗不平等的算法验证

STRUCTURAL HEART-THE JOURNAL OF THE HEART TEAM

IF2.8

2026-01-010

OAAI

Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-07-285

OAAI

Tinker, tailor, soldier, cell: the role of C-type lectins in the defense and promotion of disease

IF12.8

2022-07-155

OAAI

Carbohydrates from Pseudomonas aeruginosa biofilms interact with immune C-type lectins and interfere with their receptor function

NPJ BIOFILMS AND MICROBIOMES

IF9.2

2021-12-0821

OAAI

REPLY TO MORTENSEN ET AL.: The zymogen form of complement component C1

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2018-04-131

OAAI

Response to the comments on Direct quantitative measurement of the kinetics of HLA-specific antibody interactions with isolated HLA proteins

HUMAN IMMUNOLOGY

IF2.2

2018-02-012

PREAI

Direct quantitative measurement of the kinetics of HLA-specific antibody interactions with isolated HLA proteins

HUMAN IMMUNOLOGY

IF2.2

2018-02-0117

OAAI

Structure of the C1r-C1s interaction of the C1 complex of complement activation

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2018-01-0853

OAAI

Combinatorial peptide-based epitope mapping from Ebola virus DNA vaccines and infections reveals residue-level determinants of antibody binding

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2017-09-187

OAAI

Epitope mapping of Ebola virus dominant and subdominant glycoprotein epitopes facilitates construction of an epitope-based DNA vaccine able to focus the antibody response in mice

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2017-07-1210

OAAI

A chemical genomics approach to drug reprofiling in oncology: Antipsychotic drug risperidone as a potential adenocarcinoma treatment

IF10.1

2017-05-0129

OAAI

Specific and Differential Binding of N-Acetylgalactosamine Glycopolymers to the Human Macrophage Galactose Lectin and Asialoglycoprotein Receptor

BIOMACROMOLECULES

IF5.4

2017-04-1834

OAAI

Manipulation of cytokine secretion in human dendritic cells using glycopolymers with picomolar affinity for DC-SIGN

CHEMICAL SCIENCE

IF7.4

2017-01-0130

OAAI

Complement Protein C1q Interacts with DC-SIGN via Its Globular Domain and Thus May Interfere with HIV-1 Transmission

FRONTIERS IN IMMUNOLOGY

IF5.9

2016-12-228

OAAI

Fast Nanoscale Surface Charge Mapping with Pulsed-Potential Scanning Ion Conductance Microscopy

ANALYTICAL CHEMISTRY

IF6.7

2016-11-0263

OAAI

WHEN IS A PROSTAGLANDIN NOT A PROSTAGLANDIN?

IF2.5

2016-09-010

PREAI

Generation and characterization of β1,2-gluco-oligosaccharide probes from Brucella abortus cyclic β-glucan and their recognition by C-type lectins of the immune system

流产布鲁氏菌环状 β-葡聚糖 β1，2-葡寡糖探针的产生和表征及其对免疫系统C型凝集素的识别

IF3.3

2016-04-0616

OAAI

Enhanced non-vitreous cryopreservation of immortalized and primary cells by ice-growth inhibiting polymers

BIOMATERIALS SCIENCE

IF5.7

2016-01-0143

OAAI

Glycerol-Free Cryopreservation of Red Blood Cells Enabled by Ice-Recrystallization-Inhibiting Polymers

ACS BIOMATERIALS SCIENCE & ENGINEERING

IF5.5

2015-08-0774

OA

Novel Small Molecule Entry Inhibitors of Ebola Virus

新型小分子埃博拉病毒进入抑制剂

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2015-07-2250

OAAI